Page last updated: 2024-10-24

carvedilol and Lung Diseases, Interstitial

carvedilol has been researched along with Lung Diseases, Interstitial in 2 studies

Lung Diseases, Interstitial: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shimada, YJ1
Sato, K1
Hanon, S1
Schweitzer, P1
Wada, Y1
Kobayashi, D1
Murakami, S1
Oda, M1
Hanawa, H1
Kuroda, T1
Nakano, M1
Narita, I1

Other Studies

2 other studies available for carvedilol and Lung Diseases, Interstitial

ArticleYear
Termination of recurrent ventricular tachycardia by continuous positive airway pressure ventilation.
    Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc, 2009, Volume: 14, Issue:4

    Topics: Adrenergic beta-Antagonists; Aged; Amiodarone; Anti-Arrhythmia Agents; Carbazoles; Cardiomyopathy, H

2009
Cardiac AA amyloidosis in a patient with rheumatoid arthritis and systemic sclerosis: the therapeutic potential of biological reagents.
    Scandinavian journal of rheumatology, 2011, Volume: 40, Issue:5

    Topics: Aged; Amyloidosis; Antibodies, Antinuclear; Antirheumatic Agents; Arthritis, Rheumatoid; Benzimidazo

2011